Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating carbohydrate concentration (HP:0011013)help
Parent Node:
expand
Abnormal glucose homeostasis (HP:0011014)help
..Starting node
..expand
Insulin resistance (HP:0000855)help
Term ID: 855
Name: Insulin resistance
Synonym: Body fails to respond to insulin
Definition: Increased resistance towards insulin, that is, diminished effectiveness of insulin in reducing blood glucose levels.
Comments:
Reference: HP:0000855
Genes and Diseases:
 
       Child Nodes:
........expandInsulin-resistant diabetes mellitus (HP:0000831) help
................... HP:0000857 Neonatal insulin-dependent diabetes mellitus
................... HP:0000877 Insulin-resistant diabetes mellitus at puberty

 Sister Nodes: 
..expandAbnormal blood glucose concentration (HP:0011015) help
..expandAbnormal C-peptide level (HP:0030794) help
..expandAbnormality of urine glucose concentration (HP:0011016) help
..expandDiabetes mellitus (HP:0000819) help
..expandGlucose intolerance (HP:0001952) help
..expandHyperinsulinemia (HP:0000842) help
..expandImpaired gluconeogenesis (HP:0005959) help
..expandIncreased proinsulin:insulin ratio (HP:0031883) help
..expandInsulin insensitivity (HP:0008189) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0000855HP:0000855Insulin resistance0ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1125359600509
HP:0000855HP:0000855Insulin resistance0ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1112559600509
HP:0000855HP:0000855Insulin resistance0AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1205325603100
HP:0000855HP:0000855Insulin resistance0AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1203325603100
HP:0000855HP:0000855Insulin resistance0AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM194392164731
HP:0000855HP:0000855Insulin resistance0AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM177392164731
HP:0000855HP:0000855Insulin resistance0ALMS1 CL E G H784064ORPHA13342428606844
HP:0000855HP:0000855Insulin resistance0ALMS1 CL E G H784064ORPHA12504428606844
HP:0000855HP:0000855Insulin resistance0BSCL2 CL E G H26580363400ORPHA137315832606158
HP:0000855HP:0000855Insulin resistance0BSCL2 CL E G H26580363400ORPHA133015832606158
HP:0000855HP:0000855Insulin resistance0BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA137315832606158
HP:0000855HP:0000855Insulin resistance0BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA133015832606158
HP:0000855HP:0000855Insulin resistance0CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1851527601047
HP:0000855HP:0000855Insulin resistance0CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1811527601047
HP:0000855HP:0000855Insulin resistance0CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1811527601047
HP:0000855HP:0000855Insulin resistance0CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1851527601047
HP:0000855HP:0000855Insulin resistance0CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1851527601047
HP:0000855HP:0000855Insulin resistance0CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1811527601047
HP:0000855HP:0000855Insulin resistance0CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11109688603198
HP:0000855HP:0000855Insulin resistance0CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11099688603198
HP:0000855HP:0000855Insulin resistance0CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11109688603198
HP:0000855HP:0000855Insulin resistance0CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11099688603198
HP:0000855HP:0000855Insulin resistance0CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM117828209615586
HP:0000855HP:0000855Insulin resistance0CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM114228209615586
HP:0000855HP:0000855Insulin resistance0CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12882594107910
HP:0000855HP:0000855Insulin resistance0CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12722594107910
HP:0000855HP:0000855Insulin resistance0FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1293796164810
HP:0000855HP:0000855Insulin resistance0GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM16244195138079
HP:0000855HP:0000855Insulin resistance0GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM15644195138079
HP:0000855HP:0000855Insulin resistance0HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM157911630189907
HP:0000855HP:0000855Insulin resistance0HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM154511630189907
HP:0000855HP:0000855Insulin resistance0HSD3B2 CL E G H328490791ORPHA11885218613890
HP:0000855HP:0000855Insulin resistance0HSD3B2 CL E G H328490791ORPHA11725218613890
HP:0000855HP:0000855Insulin resistance0IGF1 CL E G H347973272ORPHA11705464147440
HP:0000855HP:0000855Insulin resistance0IGF1 CL E G H347973272ORPHA11785464147440
HP:0000855HP:0000855Insulin resistance0IGFALS CL E G H3483140941ORPHA11585468601489
HP:0000855HP:0000855Insulin resistance0IGFALS CL E G H3483140941ORPHA11605468601489
HP:0000855HP:0000855Insulin resistance0LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1826621151750
HP:0000855HP:0000855Insulin resistance0LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1786621151750
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H4000280365ORPHA113476636150330
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H40002348ORPHA114866636150330
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H400079084ORPHA114866636150330
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H400090153ORPHA114866636150330
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H40002348ORPHA113476636150330
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H400079084ORPHA113476636150330
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H400090153ORPHA113476636150330
HP:0000855HP:0000855Insulin resistance0LMNA CL E G H4000280365ORPHA114866636150330
HP:0000855HP:0000855Insulin resistance0MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA182416877608507
HP:0000855HP:0000855Insulin resistance0MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA194416877608507
HP:0000855HP:0000855Insulin resistance0PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11308618167413
HP:0000855HP:0000855Insulin resistance0PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11108618167413
HP:0000855HP:0000855Insulin resistance0PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA13078979171833
HP:0000855HP:0000855Insulin resistance0PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA12628979171833
HP:0000855HP:0000855Insulin resistance0POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM131249175174761
HP:0000855HP:0000855Insulin resistance0POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM127829175174761
HP:0000855HP:0000855Insulin resistance0PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11249236601487
HP:0000855HP:0000855Insulin resistance0PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11089236601487
HP:0000855HP:0000855Insulin resistance0PPP1R3A CL E G H5506125853Diabetes mellitus type 2125853C0011860OMIM1659291600917
HP:0000855HP:0000855Insulin resistance0WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1194712791604611
HP:0000855HP:0000855Insulin resistance0WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1239112791604611
HP:0000855HP:0000855Insulin resistance0XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM16812831194363
HP:0000855HP:0000855Insulin resistance0XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM15412831194363
HP:0000855HP:0000855Insulin resistance0ZMPSTE24 CL E G H1026990154ORPHA114912877606480
HP:0000855HP:0000855Insulin resistance0ZMPSTE24 CL E G H1026990154ORPHA116712877606480
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1125359600509
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1112559600509
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1205325603100
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1203325603100
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM194392164731
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM177392164731
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1ALMS1 CL E G H784064ORPHA13342428606844
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1ALMS1 CL E G H784064ORPHA12504428606844
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1BSCL2 CL E G H26580363400ORPHA137315832606158
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1BSCL2 CL E G H26580363400ORPHA133015832606158
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA137315832606158
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA133015832606158
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1851527601047
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1811527601047
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1811527601047
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1851527601047
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1851527601047
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1811527601047
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11109688603198
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11099688603198
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11109688603198
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11099688603198
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM117828209615586
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM114228209615586
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12882594107910
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12722594107910
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1293796164810
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM16244195138079
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM15644195138079
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM157911630189907
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM154511630189907
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1HSD3B2 CL E G H328490791ORPHA11885218613890
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1HSD3B2 CL E G H328490791ORPHA11725218613890
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1IGF1 CL E G H347973272ORPHA11705464147440
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1IGF1 CL E G H347973272ORPHA11785464147440
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1IGFALS CL E G H3483140941ORPHA11585468601489
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1IGFALS CL E G H3483140941ORPHA11605468601489
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1826621151750
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1786621151750
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H4000280365ORPHA113476636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H40002348ORPHA114866636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H400079084ORPHA114866636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H400090153ORPHA114866636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H40002348ORPHA113476636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H400079084ORPHA113476636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H400090153ORPHA113476636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNA CL E G H4000280365ORPHA114866636150330
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA182416877608507
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA194416877608507
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11308618167413
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11108618167413
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA13078979171833
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA12628979171833
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM131249175174761
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM127829175174761
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11249236601487
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11089236601487
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1PPP1R3A CL E G H5506125853Diabetes mellitus type 2125853C0011860OMIM1659291600917
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1194712791604611
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1239112791604611
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM16812831194363
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM15412831194363
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1ZMPSTE24 CL E G H1026990154ORPHA114912877606480
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1ZMPSTE24 CL E G H1026990154ORPHA116712877606480
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1125359600509
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1112559600509
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1125359600509
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1112559600509
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1205325603100
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1203325603100
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1205325603100
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1203325603100
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM194392164731
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM177392164731
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM194392164731
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM177392164731
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2ALMS1 CL E G H784064ORPHA13342428606844
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2ALMS1 CL E G H784064ORPHA12504428606844
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2ALMS1 CL E G H784064ORPHA13342428606844
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2ALMS1 CL E G H784064ORPHA12504428606844
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2BSCL2 CL E G H26580363400ORPHA133015832606158
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2BSCL2 CL E G H26580363400ORPHA137315832606158
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2BSCL2 CL E G H26580363400ORPHA133015832606158
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2BSCL2 CL E G H26580363400ORPHA137315832606158
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA137315832606158
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA133015832606158
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA137315832606158
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA133015832606158
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1851527601047
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1811527601047
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1851527601047
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1811527601047
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1811527601047
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1851527601047
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1811527601047
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1851527601047
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1811527601047
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1851527601047
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1811527601047
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1851527601047
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11109688603198
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11099688603198
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11109688603198
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11099688603198
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11099688603198
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11109688603198
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11099688603198
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11109688603198
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM117828209615586
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM114228209615586
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM117828209615586
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM114228209615586
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12882594107910
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12722594107910
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12882594107910
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12722594107910
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1293796164810
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1293796164810
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM16244195138079
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM15644195138079
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM16244195138079
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM15644195138079
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM157911630189907
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM154511630189907
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM157911630189907
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM154511630189907
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2HSD3B2 CL E G H328490791ORPHA11725218613890
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2HSD3B2 CL E G H328490791ORPHA11885218613890
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2HSD3B2 CL E G H328490791ORPHA11725218613890
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2HSD3B2 CL E G H328490791ORPHA11885218613890
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2IGF1 CL E G H347973272ORPHA11705464147440
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2IGF1 CL E G H347973272ORPHA11785464147440
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2IGF1 CL E G H347973272ORPHA11705464147440
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2IGF1 CL E G H347973272ORPHA11785464147440
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2IGFALS CL E G H3483140941ORPHA11585468601489
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2IGFALS CL E G H3483140941ORPHA11605468601489
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2IGFALS CL E G H3483140941ORPHA11585468601489
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2IGFALS CL E G H3483140941ORPHA11605468601489
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1826621151750
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1786621151750
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1826621151750
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1786621151750
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H40002348ORPHA113476636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H4000280365ORPHA113476636150330
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H400079084ORPHA113476636150330
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H400090153ORPHA113476636150330
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H4000280365ORPHA114866636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H40002348ORPHA114866636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H400079084ORPHA114866636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H400090153ORPHA114866636150330
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H4000280365ORPHA113476636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H40002348ORPHA113476636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H400079084ORPHA113476636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H400090153ORPHA113476636150330
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H40002348ORPHA114866636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNA CL E G H4000280365ORPHA114866636150330
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H400079084ORPHA114866636150330
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNA CL E G H400090153ORPHA114866636150330
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA182416877608507
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA194416877608507
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA182416877608507
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA194416877608507
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11308618167413
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11108618167413
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11308618167413
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11108618167413
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA12628979171833
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA13078979171833
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA12628979171833
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA13078979171833
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM131249175174761
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM127829175174761
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM131249175174761
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM127829175174761
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11089236601487
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11249236601487
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11089236601487
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11249236601487
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2PPP1R3A CL E G H5506125853Diabetes mellitus type 2125853C0011860OMIM1659291600917
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2PPP1R3A CL E G H5506125853Diabetes mellitus type 2125853C0011860OMIM1659291600917
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1194712791604611
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1239112791604611
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1194712791604611
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1239112791604611
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM16812831194363
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM15412831194363
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM16812831194363
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM15412831194363
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2ZMPSTE24 CL E G H1026990154ORPHA114912877606480
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2ZMPSTE24 CL E G H1026990154ORPHA116712877606480
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2ZMPSTE24 CL E G H1026990154ORPHA114912877606480
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2ZMPSTE24 CL E G H1026990154ORPHA116712877606480
HP:0000855HP:0008255Transient neonatal diabetes mellitus3ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1125359600509
HP:0000855HP:0008255Transient neonatal diabetes mellitus3ABCC8 CL E G H6833125853Diabetes mellitus type 2125853C0011860OMIM1112559600509
HP:0000855HP:0008255Transient neonatal diabetes mellitus3AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1205325603100
HP:0000855HP:0008255Transient neonatal diabetes mellitus3AGPAT2 CL E G H10555528Acute myeloblastic leukemia type 3ORPHA1203325603100
HP:0000855HP:0008255Transient neonatal diabetes mellitus3AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM194392164731
HP:0000855HP:0008255Transient neonatal diabetes mellitus3AKT2 CL E G H208125853Diabetes mellitus type 2125853C0011860OMIM177392164731
HP:0000855HP:0008255Transient neonatal diabetes mellitus3ALMS1 CL E G H784064ORPHA13342428606844
HP:0000855HP:0008255Transient neonatal diabetes mellitus3ALMS1 CL E G H784064ORPHA12504428606844
HP:0000855HP:0008255Transient neonatal diabetes mellitus3BSCL2 CL E G H26580363400ORPHA133015832606158
HP:0000855HP:0008255Transient neonatal diabetes mellitus3BSCL2 CL E G H26580363400ORPHA137315832606158
HP:0000855HP:0008255Transient neonatal diabetes mellitus3BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA137315832606158
HP:0000855HP:0008255Transient neonatal diabetes mellitus3BSCL2 CL E G H26580528Acute myeloblastic leukemia type 3ORPHA133015832606158
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1851527601047
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAV1 CL E G H857528Acute myeloblastic leukemia type 3ORPHA1811527601047
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1851527601047
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAV1 CL E G H857612526Lipodystrophy, congenital generalized, type 3612526C2675861OMIM1811527601047
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1811527601047
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAV1 CL E G H857606721Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome606721C1847582OMIM1851527601047
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11109688603198
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAVIN1 CL E G H284119528Acute myeloblastic leukemia type 3ORPHA11099688603198
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11099688603198
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11109688603198
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM117828209615586
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CEP19 CL E G H84984615703Morbid obesity and spermatogenic failure615703C3810324OMIM114228209615586
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12882594107910
HP:0000855HP:0008255Transient neonatal diabetes mellitus3CYP19A1 CL E G H158891Malignant melanoma, childhoodORPHA12722594107910
HP:0000855HP:0008255Transient neonatal diabetes mellitus3FOS CL E G H2353528Acute myeloblastic leukemia type 3ORPHA1293796164810
HP:0000855HP:0008255Transient neonatal diabetes mellitus3GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM16244195138079
HP:0000855HP:0008255Transient neonatal diabetes mellitus3GCK CL E G H2645125853Diabetes mellitus type 2125853C0011860OMIM15644195138079
HP:0000855HP:0008255Transient neonatal diabetes mellitus3HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM157911630189907
HP:0000855HP:0008255Transient neonatal diabetes mellitus3HNF1B CL E G H6928125853Diabetes mellitus type 2125853C0011860OMIM154511630189907
HP:0000855HP:0008255Transient neonatal diabetes mellitus3HSD3B2 CL E G H328490791ORPHA11725218613890
HP:0000855HP:0008255Transient neonatal diabetes mellitus3HSD3B2 CL E G H328490791ORPHA11885218613890
HP:0000855HP:0008255Transient neonatal diabetes mellitus3IGF1 CL E G H347973272ORPHA11785464147440
HP:0000855HP:0008255Transient neonatal diabetes mellitus3IGF1 CL E G H347973272ORPHA11705464147440
HP:0000855HP:0008255Transient neonatal diabetes mellitus3IGFALS CL E G H3483140941ORPHA11605468601489
HP:0000855HP:0008255Transient neonatal diabetes mellitus3IGFALS CL E G H3483140941ORPHA11585468601489
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1826621151750
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM1786621151750
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H40002348ORPHA113476636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H400079084ORPHA113476636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H400090153ORPHA113476636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H4000280365ORPHA114866636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H4000280365ORPHA113476636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H40002348ORPHA114866636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H400079084ORPHA114866636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNA CL E G H400090153ORPHA114866636150330
HP:0000855HP:0008255Transient neonatal diabetes mellitus3MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA194416877608507
HP:0000855HP:0008255Transient neonatal diabetes mellitus3MFN2 CL E G H99272398Froster Iskenius Waterson syndromeORPHA182416877608507
HP:0000855HP:0008255Transient neonatal diabetes mellitus3PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11308618167413
HP:0000855HP:0008255Transient neonatal diabetes mellitus3PAX4 CL E G H5078125853Diabetes mellitus type 2125853C0011860OMIM11108618167413
HP:0000855HP:0008255Transient neonatal diabetes mellitus3PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA12628979171833
HP:0000855HP:0008255Transient neonatal diabetes mellitus3PIK3R1 CL E G H52953163Lactic acidosis congenital infantileORPHA13078979171833
HP:0000855HP:0008255Transient neonatal diabetes mellitus3POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM131249175174761
HP:0000855HP:0008255Transient neonatal diabetes mellitus3POLD1 CL E G H5424615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome615381C3715192OMIM127829175174761
HP:0000855HP:0008255Transient neonatal diabetes mellitus3PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11089236601487
HP:0000855HP:0008255Transient neonatal diabetes mellitus3PPARG CL E G H5468528Acute myeloblastic leukemia type 3ORPHA11249236601487
HP:0000855HP:0008255Transient neonatal diabetes mellitus3PPP1R3A CL E G H5506125853Diabetes mellitus type 2125853C0011860OMIM1659291600917
HP:0000855HP:0008255Transient neonatal diabetes mellitus3WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1239112791604611
HP:0000855HP:0008255Transient neonatal diabetes mellitus3WRN CL E G H7486902Blepharo naso facial syndrome Van maldergem typeORPHA1194712791604611
HP:0000855HP:0008255Transient neonatal diabetes mellitus3XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM16812831194363
HP:0000855HP:0008255Transient neonatal diabetes mellitus3XRCC4 CL E G H7518616541Short stature, microcephaly, and endocrine dysfunction616541C4225288OMIM15412831194363
HP:0000855HP:0008255Transient neonatal diabetes mellitus3ZMPSTE24 CL E G H1026990154ORPHA116712877606480
HP:0000855HP:0008255Transient neonatal diabetes mellitus3ZMPSTE24 CL E G H1026990154ORPHA114912877606480
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000855HP:0000855Insulin resistance0HSD11B1 CL E G H3290614662Cortisone reductase deficiency 2614662C3553382OMIM0285208600713
HP:0000855HP:0000855Insulin resistance0INSR CL E G H3643263458ORPHA05416091147670
HP:0000855HP:0000855Insulin resistance0INSR CL E G H3643263458ORPHA05086091147670
HP:0000855HP:0000855Insulin resistance0LMNB2 CL E G H8482379087ORPHA03146638150341
HP:0000855HP:0000855Insulin resistance0LMNB2 CL E G H8482379087ORPHA03886638150341
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1HSD11B1 CL E G H3290614662Cortisone reductase deficiency 2614662C3553382OMIM0285208600713
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1INSR CL E G H3643263458ORPHA05416091147670
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1INSR CL E G H3643263458ORPHA05086091147670
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNB2 CL E G H8482379087ORPHA03146638150341
HP:0000855HP:0000831Insulin-resistant diabetes mellitus1LMNB2 CL E G H8482379087ORPHA03886638150341
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2HSD11B1 CL E G H3290614662Cortisone reductase deficiency 2614662C3553382OMIM0285208600713
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2HSD11B1 CL E G H3290614662Cortisone reductase deficiency 2614662C3553382OMIM0285208600713
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2INSR CL E G H3643263458ORPHA05086091147670
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2INSR CL E G H3643263458ORPHA05416091147670
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2INSR CL E G H3643263458ORPHA05086091147670
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2INSR CL E G H3643263458ORPHA05416091147670
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNB2 CL E G H8482379087ORPHA03146638150341
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNB2 CL E G H8482379087ORPHA03886638150341
HP:0000855HP:0000877Insulin-resistant diabetes mellitus at puberty2LMNB2 CL E G H8482379087ORPHA03146638150341
HP:0000855HP:0000857Neonatal insulin-dependent diabetes mellitus2LMNB2 CL E G H8482379087ORPHA03886638150341
HP:0000855HP:0008255Transient neonatal diabetes mellitus3HSD11B1 CL E G H3290614662Cortisone reductase deficiency 2614662C3553382OMIM0285208600713
HP:0000855HP:0008255Transient neonatal diabetes mellitus3INSR CL E G H3643263458ORPHA05086091147670
HP:0000855HP:0008255Transient neonatal diabetes mellitus3INSR CL E G H3643263458ORPHA05416091147670
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNB2 CL E G H8482379087ORPHA03886638150341
HP:0000855HP:0008255Transient neonatal diabetes mellitus3LMNB2 CL E G H8482379087ORPHA03146638150341


Genes (45) :ABCC8 AGPAT2 AKT2 ALMS1 BSCL2 CAV1 CAVIN1 CEP19 CIDEC CYP19A1 DCAF17 EIF2AK3 FOS GATA6 GCK HNF1B HSD11B1 HSD3B2 HYMAI IGF1 IGFALS INS INSR KCNJ11 LEP LEPR LIPE LMNA LMNB2 MFN2 NSMCE2 PAX4 PDX1 PIK3R1 PLAGL1 PLIN1 POLD1 PPARG PPP1R3A PTF1A STAT3 WRN XRCC4 ZFP57 ZMPSTE24

Diseases (57) :125853 528 64 363400 612526 606721 613327 615703 91 614662 90791 73272 140941 263458 615980 280365 2348 90153 79084 79087 2398 3163 615381 902 616541 90154 79085 203800 435651 3464 226980 262190 66628 179494 435660 79474 151660 248370 436182 269880 79083 604367 608612 99885 608594 269700 2255 96191 740 260370 280356 65288 99886 610374 1667 601410 610582
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.